Atkins Plus KetoCal for Childhood Epilepsy
Completed · Phase 3
Conditions studied: Epilepsy
In brief
The modified Atkins diet (MAD) is a relatively new, alternative dietary therapy for intractable childhood and adult epilepsy. Recent evidence suggests that a strict, highly ketotic, first month may be advantageous to both immediate and long-term efficacy. KetoCal® is a pre-mixed powder that can be used to create a 4:1 ketogenic diet shake as a meal substitute. The investigators hypothesize that substituting KetoCal® for a lunch during the initial month of the MAD will lead to improved seizure reduction over the MAD alone, as well as improved tolerability and lipid values.
Key facts
- Study ID
- NCT00681239
- Run by
- Johns Hopkins University
- People needed
- 30
- Starts
- 2008-05-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2009-12-31
Who can join
Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Children ages 3-17 years
- At least daily seizures (or 7 per week). All seizure types allowed
- Tried at least two anticonvulsants
You may not qualify if…
- Unwilling to restrict carbohydrates
- Significantly underweight (BMI ≤ 5%)
- Prior use of the modified Atkins diet for ≥ 2 days
- Prior use of KetoCal® at any time for any duration
- Use of the KD within the past year
- Kidney disease
- History of hypercholesterolemia(>300 mg/dl) or hypertriglyceridemia (>200 mg/dl)
- Metabolic or mitochondrial disorder
- Aversion to shakes or inability to eat solid food
Where it is running
- Johns Hopkins Hospital — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.